Values First Advisors »

Arrowhead Pharmaceuticals shares owned by Values First Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Values First Advisors from 13F filings

Historical chart of Values First Advisors investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Values First Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Values First Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $52k 2.7k 19.37

More positions owned by Values First Advisors

Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ensign (ENSG)
Emergent BioSolutions (EBS)
Monolithic Power Systems (MPWR)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Mid-America Apartment (MAA)
National Retail Properties (NNN)
Ishares U S Etf Tr Blackrock Sh Dur (NEAR)
Vaalco Energy Com New (EGY)
LeMaitre Vascular (LMAT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Values First Advisors

Top funds holding Arrowhead Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Slate Path Capital
T. Rowe Price Investment Management
Geode Capital Management
Siren
Jpmorgan Chase & Co
Morgan Stanley
Northern Trust
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management
Rokos Capital Management

View all funds holding Arrowhead Pharmaceuticals